PathAdvantage

New insights from a recent study highlight the benefits of examining both Pap tests and cervical biopsies within the same institution. This approach enhances the accuracy of diagnoses through cytology-histology correlation (CHC) and reduces discrepancies and unnecessary anxiety for patients. Why does this matter? Consolidating these tests in one institution leads to more precise care and better treatment decisions. Learn how PathAdvantage achieves better patient outcomes through integrated diagnostic practices in our journal. https://lnkd.in/gix2iqjT

From bartending to biopsies—learn about Dr. Richard Hopley’s path to pathology in our latest article. Today, as associate medical director at PathAdvantage, he’s passionate about solving medical puzzles and advancing patient care. https://lnkd.in/g_aAyjvd

Do you know the differences between the roles of a pathologist and an oncologist? While both specialize in diagnosing cancer, oncologists are trained to treat it, sometimes focusing on specific methods like radiation or chemotherapy, or particular cancers such as breast or prostate cancer. Pathologists study body fluids, cells, and tissues to diagnose diseases, especially cancer. They rarely have direct patient contact — so you may not meet your pathologist — but their findings guide oncologists in determining the next steps for treatment. That’s why the pathologist is called the “doctor’s doctor.” At PathAdvantage, our expert pathologists work diligently to test and screen patients to catch cancer early, ensuring timely and effective treatment.

Gonorrhea has become resistant to nearly EVERY class of antibiotic used to treat it! Accordingly, the CDC has changed its recommended regimen for the treatment of gonococcal infections. Here is the new regimen: Medication, mainly ceftriaxone, should be provided immediately after diagnosis. Further STI testing for chlamydia, syphilis, and HIV is recommended, as well as treatment of current or past sexual partners, and abstaining from sexual activity for 7 days. Retest after three months to be sure the infection has not returned. Learn more about the organisms we test for by ordering or downloading our Bug Book, a comprehensive reference on all vaginal pathological agents. https://buff.ly/3CiCyu5

Your new secret weapon: The Bug Book! Our comprehensive guide provides up-to-date references and recommended treatments for over 50 gynecologic-related infectious agents. With updates every two years, including new discussions on lactobacillus and ulcerative STIs, you’ll always have the latest information at your fingertips. Download the Bug Book app now! ?? App Store: https://buff.ly/40Hqc85 Google Play: https://buff.ly/42qTKIq

Ninety percent of UTIs are caused by Escherichia coli bacteria, also known as E. coli. Due to rising resistance in commonly used antibiotics, especially for E. coli, it is more important than ever that UTI diagnosis and treatment are timely and correct so antibiotics are not incorrectly prescribed. PathAdvantage is proud to offer a unique, first of its kind FDA approved technology that allows for rapid, essentially 100% sensitive confirmation of negative urine cultures in only three hours so clinicians can receive same-day results. All positive UTI results are reflexed to culture and sensitivity to ensure proper antibiotic treatment. Learn more about the organisms we test for by ordering or downloading our Bug Book, a comprehensive reference on all vaginal pathological agents. https://buff.ly/3CiCyu5

We treat your patients like our patients and want to ensure their healthcare journey is as stress-free as possible. That’s why we avoid exclusivity agreements with insurers, ensuring our testing is covered by all eligible insurance plans and programs. We also offer a wide array of tests including GYN, non-GYN, and anal cytology; anatomic pathology with subspecialists in GYN and dermatopathology; infectious agent detection with sensitivity testing; clinical testing of blood and urine. This way, your patients won’t have to get results (or bills) from more than one lab.

At PathAdvantage, we are continually evaluating new technology in our effort to provide clinicians highly accurate results with a 24 hour turnaround time. In no area could this be more important than testing for Group B Streptococcus in pregnant patients. To that end, recently adopted Nucleic Acid Amplification Tests (NAATs), as featured in a recent issue of CAP Today. GBS is a bacterium naturally found in the lower genital tract of about 25% of pregnant women in the US. While usually harmless to mothers, it can cause serious infections and even death in newborns. With proper detection and treatment prior to giving birth, it's completely preventable. NAAT testing provides higher sensitivity and a faster turnaround time than previously available methods such as culturing, which could take up to seven days. A fast turnaround time is key ensuring the patient does not go into labor before getting results. Before adopting this new technology, we conducted thorough research and validation of different testing platforms. Our new technology, the Panther Fusion GBS assay, successfully passed all validation requirements even demonstrating a higher sensitivity than previous methods, which was consistent with findings described in published literature. We are proud to offer this efficient, accurate, and fast testing method to our clinicians. SOURCES: Shin JH and Pride DT. Comparison of Three Nucleic Acid Amplification Tests (NAATs) and Culture for Detection of Group B Streptococcus (GBS) from Enrichment Broth. J Clin Microbiol JCM.01958-18; DOI: 10.1128/JCM.01958-18.

With increasing antibiotic resistance, therapy guided by resistance testing becomes more and more critical for doctors deciding on the best treatment. Discover more on the latest testing methods in the newly released eighth edition of The Bug Book. Get your copy today and stay informed on cutting-edge advancements in antibiotic resistance management. https://buff.ly/47rAds0

Looking for a comprehensive, accurate, and user-friendly reference for treating various gynecologic-related infectious agents? The eighth edition of The Bug Book is out now. Available in both digital and hardcopy formats, it provides up-to-date information on diverse organisms and medical conditions, making it an essential tool for medical professionals. Enhance your practice and patient care with this essential guide. Grab your copy today! https://buff.ly/4ed601V